TickerHumSide-by-side comparison
Edwards Lifesciences vs Stryker
As of Nov 11, 2026, P/E is 59.3x for Edwards Lifesciences vs 33.9x for Stryker; P/S is 9.0x for Edwards Lifesciences vs 4.6x for Stryker; revenue growth is 13.4% for Edwards Lifesciences vs 7.9% for Stryker; operating margin is 21.6% for Edwards Lifesciences vs 20.7% for Stryker.
What stands out
- Stryker is cheaper on earnings: 33.9x P/E vs 59.3x for Edwards Lifesciences.
- Edwards Lifesciences carries less debt relative to equity: 0.06 vs 0.60 for Stryker.
- Edwards Lifesciences's shares did better over the past year: +22.7% vs -13.3% for Stryker.
Key metrics
| Metric | EW | SYK |
|---|---|---|
| Price | $104.98 | $318.35 |
| Market cap | $60.36B | $121.19B |
| P/E | 59.3x (#2) | 33.9x (#1) |
| P/S | 9.0x (#2) | 4.6x (#1) |
| Revenue growth | 13.4% (#1) | 7.9% (#2) |
| Operating margin | 21.6% (#1) | 20.7% (#2) |
| Net margin | 15.3% (#1) | 13.8% (#2) |
| Debt / equity | 0.06 (#1) | 0.60 (#2) |
| 1-year return | +22.7% (#1) | -13.3% (#2) |
| Research score | 66/100 (#1) | 59/100 (#2) |
Higher is better for growth, margins, one-year return and overall score; lower is better for valuation and debt ratios. Ties share a rank and missing values are excluded.
Company research
- Edwards Lifesciences Corporation (EW) — Medical Devices
- Stryker Corporation (SYK) — Medical Devices